Fidelity Investments’s Cumberland Pharmaceuticals CPIX Stock Holding History

Fidelity Investments’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$136	Buy	+21	New	+$101	﹤0.01%	5386
2021 Q3	–	Sell	-422	Closed	-$1K	–	4421
2021 Q2	$1K	Hold	422	–	–	﹤0.01%	4012
2021 Q1	$1K	Hold	422	–	–	﹤0.01%	3815
2020 Q4	$1K	Hold	422	–	–	﹤0.01%	3668
2020 Q3	$1K	Hold	422	–	–	﹤0.01%	3539
2020 Q2	$1K	Buy	+422	New	+$1.53K	﹤0.01%	3442

Other funds holding CPIX

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments's CPIX Position: Q2 2026 in Review

Fidelity Investments opened a new position in Cumberland Pharmaceuticals (CPIX) in Q2 2026: 21 shares worth $136. The stake represents ﹤0.01% of the portfolio and ranks #5386 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in CPIX as recently as Q2 2021.

Fidelity Investments first reported a position in CPIX in Q2 2020 and has held it in 6 quarters since. The position peaked at $1K in Q2 2021. 32 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

Fidelity Investments held 21 shares of Cumberland Pharmaceuticals worth $136 as of Q2 2026.
Cumberland Pharmaceuticals was a new Fidelity Investments position in Q2 2026.
Cumberland Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5386 holding.
Fidelity Investments first reported a position in Cumberland Pharmaceuticals in Q2 2020 and has held it in 6 quarters since.
Fidelity Investments's Cumberland Pharmaceuticals position peaked at $1K in Q2 2021.
32 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.